Reports for SANIS HEALTH INC

Company Name

SANIS HEALTH INC

Totals

Shortage reports

445

Actual shortage: 54 (12%)
Anticipated shortage: 15 (3%)
Avoided shortage: 8 (2%)
Resolved: 368 (83%)

Discontinuation Reports

68

To be discontinued: 7 (10%)
Discontinued: 51 (75%)
Reversed: 10 (15%)

Late reports

44 (9%)

Overdue reports

12 (16%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BUPROPION SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-12 2024-03-02 144044
BUPROPION SR 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-12 2024-03-02 144047
TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-22 2024-04-05 211102
TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-17 2024-02-29 216290
TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-20 2024-04-07 222839
QUETIAPINE FUMARATE XR 50MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223344
QUETIAPINE FUMARATE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-25 2024-04-14 223281
QUETIAPINE FUMARATE XR 200MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223380
QUETIAPINE FUMARATE XR 300MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223365
QUETIAPINE FUMARATE XR 400MG TABLET (EXTENDED-RELEASE) Anticipated shortage 2024-03-26 2024-05-08 223373
ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-27 2024-05-08 223485
GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-26 2024-03-26 223456
GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-26 2024-03-27 223453
DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-25 2024-04-19 223265
NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-25 2018-12-11 56416
NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2018-05-16 2018-08-16 49537
DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Resolved 2017-04-10 2017-04-27 6274
DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Resolved 2019-03-16 2024-03-02 78849
RABEPRAZOLE EC 10MG TABLET (ENTERIC-COATED) Actual shortage 2023-12-26 2024-05-08 214284
RABEPRAZOLE EC 20MG TABLET (ENTERIC-COATED) Resolved 2023-07-18 2023-12-01 198918

Showing 21 to 40 of 445

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACYCLOVIR 400MG TABLET Discontinued 2017-03-31 2017-03-31 4942
ROPINIROLE 5MG TABLET Discontinued 2017-03-31 2017-03-31 4945
ETIDROCAL 400MG 500MG TABLET Discontinued 2017-03-31 2017-03-31 4959
CILAZAPRIL 1MG TABLET Discontinued 2017-08-02 2017-08-02 17969
PRAMIPEXOLE 0.25MG TABLET Discontinued 2019-03-26 2019-03-27 79465
PRAMIPEXOLE 0.5MG TABLET Discontinued 2019-03-26 2019-03-27 79468
PRAMIPEXOLE 1MG TABLET Discontinued 2019-03-26 2019-03-27 79471
TRAMADOL/ACET 325MG 37.5MG TABLET Discontinued 2020-04-08 2020-07-07 111524
OXYCODONE/ACET 5MG 325MG TABLET Discontinued 2020-04-08 2020-06-09 111527
OXYCODONE/ACET 5MG 325MG TABLET Discontinued 2020-04-08 2020-06-09 111531
LORAZEPAM 1.0MG TABLET Discontinued 2021-05-17 2021-11-16 139511
LORAZEPAM 2.0MG TABLET Discontinued 2021-08-12 2022-02-06 144029
ALPRAZOLAM 0.25MG TABLET Discontinued 2021-08-12 2022-02-06 144035
ALPRAZOLAM 0.50MG TABLET Discontinued 2021-08-12 2021-12-17 144038
ALPRAZOLAM 0.50MG TABLET Discontinued 2021-08-12 2021-08-12 144041
TERAZOSIN 10MG TABLET To be discontinued 2021-12-16 2021-12-16 151275
TERAZOSIN 1MG TABLET To be discontinued 2021-12-16 2021-12-16 151278
TERAZOSIN 2MG TABLET To be discontinued 2021-12-16 2021-12-16 151281
TERAZOSIN 5MG TABLET To be discontinued 2021-12-16 2021-12-16 151284
LORAZEPAM 2.0MG TABLET Discontinued 2021-12-16 2021-12-17 151293

Showing 21 to 40 of 68